View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200, Small Cell Lung Carcinoma, Second Line
Protocol-ID: 1345 V1.1 (Mini), PEMB200, SCLC, second lineIndication(s)
- Lung Carcinoma, Small Cell (PD-L1+); ICD-10 C34.-
Links
- Keynote 158, SCLC [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 23.06.2021